Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
Clinical Lung Cancer|September 6, 2011
Retrospective analysis of third-line and fourth-line chemotherapy for advanced non-small-cell lung cancerHajime Asahina, Ikuo Sekine, Hidehito Horinouchi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|October 16, 2009
[Two cases of invasive pulmonary aspergillosis mimicking pneumonia in lung cancer patients]Hidehito Horinouchi, Sayaka Yamao, Shimpei Gotoh, et al.
Cancer Science|September 26, 2012
Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancerHidehito Horinouchi, Ikuo Sekine, Minako Sumi, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 3, 2018
Children's Knowledge of Cancer Prevention and Perceptions of Cancer Patients: Comparison Before and After Cancer Education with the Presence of Visiting Lecturer -Guided ClassHiroko Yako-Suketomo, Kota Katanoda, Yoko Kawamura, et al.
Journal of Thoracic Disease|May 1, 2018
Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisitedJun Sato, Hidehito Horinouchi, Yasushi Goto, et al.
Japanese Journal of Clinical Oncology|July 12, 2011
Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancerMakoto Furugen, Ikuo Sekine, Koji Tsuta, et al.
Molecular and Clinical Oncology|January 27, 2017
Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: Long-term follow-up resultsEmi Kubo, Noboru Yamamoto, Hiroshi Nokihara, et al.
ESMO Open|May 17, 2018
Reduction in nephrotoxicities using short hydration for chemotherapy containing cisplatin: a consecutive analysis of 467 patients with thoracic malignanciesMidori Tanaka, Hidehito Horinouchi, Yasushi Goto, et al.
Cancer Science|February 11, 2012
Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factorHidehito Horinouchi, Ikuo Sekine, Minako Sumi, et al.
Japanese Journal of Clinical Oncology|June 4, 2011
Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lungHiroshi Yoshida, Ikuo Sekine, Koji Tsuta, et al.
Pageof 22